ENTRY       D08270                      Drug
NAME        Nicardipine (INN);
            Cardene (TN)
FORMULA     C26H29N3O6
EXACT_MASS  479.2056
MOL_WEIGHT  479.525
CLASS       Cardiovascular agent
             DG01575  Calcium channel blocker
              DG01496  Calcium channel L type blocker
             DG03231  Antihypertensive
              DG01928  Dihydropyridine calcium channel blocker
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Same as: C07264
            ATC code: C08CA04
            Chemical structure group: DG00323
            Product (DG00323): D00617<JP/US>
EFFICACY    Antihypertensive, Vasodilator, Calcium channel blocker
COMMENT     Dihydropyridine derivative
TARGET      CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]
  PATHWAY   hsa04020(775+776+778+779)  Calcium signaling pathway
            hsa04260(775+776+778+779)  Cardiac muscle contraction
            hsa04261(775+776+778+779)  Adrenergic signaling in cardiomyocytes
            hsa04270(775+776+778+779)  Vascular smooth muscle contraction
METABOLISM  Enzyme: CYP3A4 [HSA:1576]
INTERACTION  
STR_MAP     map07036  Calcium channel blocking drugs
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C08 CALCIUM CHANNEL BLOCKERS
               C08C SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS
                C08CA Dihydropyridine derivatives
                 C08CA04 Nicardipine
                  D08270  Nicardipine (INN)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01575  Calcium channel blocker
               DG01496  Calcium channel L type blocker
                DG00323  Nicardipine
                 D08270  Nicardipine
              DG03231  Antihypertensive
               DG01928  Dihydropyridine calcium channel blocker
                DG00323  Nicardipine
                 D08270  Nicardipine
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00323  Nicardipine
                 D08270  Nicardipine
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Voltage-gated ion channels
               Calcium channels
                CACNA1-L
                 D08270  Nicardipine (INN)
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D08270
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01575  Calcium channel blocker
               DG01496  Calcium channel L type blocker
                DG00323  Nicardipine
              DG03231  Antihypertensive
               DG01928  Dihydropyridine calcium channel blocker
                DG00323  Nicardipine
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00323  Nicardipine
DBLINKS     CAS: 55985-32-5
            PubChem: 96024957
            ChEBI: 7550
            LigandBox: D08270
            NIKKAJI: J11.098A
ATOM        35
            1   C1y C    20.5800  -16.3800
            2   C8y C    20.5800  -17.7800
            3   C2y C    21.7700  -15.6800
            4   C2y C    19.3900  -15.6800
            5   C8x C    21.8400  -18.4800
            6   C8x C    19.3900  -18.4800
            7   C2y C    21.7700  -14.3500
            8   C7a C    23.0300  -16.3800
            9   C2y C    19.3900  -14.3500
            10  C7a C    18.2000  -16.3800
            11  C8y C    21.8400  -19.8100
            12  C8x C    19.3900  -19.8800
            13  N1x N    20.5800  -13.6500
            14  C1a C    23.0300  -13.6500
            15  O7a O    24.2200  -15.6800
            16  O6a O    23.0300  -17.7800
            17  C1a C    18.2000  -13.6500
            18  O7a O    17.0100  -15.6800
            19  O6a O    18.2000  -17.7800
            20  C8x C    20.6500  -20.5100
            21  N2b N    23.0300  -20.5100 #+
            22  C1b C    25.4100  -16.3800
            23  C1a C    15.8200  -16.3800
            24  O3a O    24.5000  -19.6000
            25  O3a O    23.0300  -22.2600 #-
            26  C1b C    26.6000  -15.6800
            27  N1c N    27.7900  -16.3800
            28  C1b C    28.9800  -15.6800
            29  C1a C    27.7900  -17.7800
            30  C8y C    30.1700  -16.3800
            31  C8x C    30.1700  -17.7800
            32  C8x C    31.3600  -15.6800
            33  C8x C    31.3600  -18.4800
            34  C8x C    32.5500  -16.3800
            35  C8x C    32.5500  -17.7800
BOND        37
            1     1   2 1
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     2   6 2
            6     3   7 2
            7     3   8 1
            8     4   9 2
            9     4  10 1
            10    5  11 2
            11    6  12 1
            12    7  13 1
            13    7  14 1
            14    8  15 1
            15    8  16 2
            16    9  17 1
            17   10  18 1
            18   10  19 2
            19   11  20 1
            20   11  21 1
            21   15  22 1
            22   18  23 1
            23   21  24 2
            24   21  25 1
            25   22  26 1
            26   26  27 1
            27   27  28 1
            28   27  29 1
            29   28  30 1
            30   30  31 2
            31   30  32 1
            32   31  33 1
            33   32  34 2
            34   33  35 2
            35    9  13 1
            36   12  20 2
            37   34  35 1
///
